System for perfusion management

Information

  • Patent Grant
  • 8337482
  • Patent Number
    8,337,482
  • Date Filed
    Monday, April 19, 2004
    20 years ago
  • Date Issued
    Tuesday, December 25, 2012
    11 years ago
Abstract
A system for perfusion management that monitors, maintains, diagnoses, or treats perfusion deficiencies.
Description
RELATED APPLICATIONS

1. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 10/827,572, entitled A SYSTEM WITH A RESERVOIR FOR PERFUSION MANAGEMENT, naming Lowell L. Wood, Jr. as inventor, filed 19 Apr. 2004, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.


2. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 10/827,578, entitled A SYSTEM WITH A SENSOR FOR PERFUSION MANAGEMENT, naming Lowell L. Wood, Jr. as inventor, filed 19 Apr. 2004, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.


3. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 10/827,390, entitled A TELESCOPING PERFUSION MANAGEMENT SYSTEM, naming Lowell L. Wood, Jr. as inventor, filed 19 Apr. 2004, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.


The United States Patent Office (USPTO) has published a notice to the effect that the USPTO's computer programs require that patent applicants reference both a serial number and indicate whether an application is a continuation or continuation-in-part. Stephen G Kunin, Benefit of Prior-Filed Application, USPTO Official Gazette Mar. 18, 2003. The present Applicant Entity (hereinafter “Applicant”) has provided above a specific reference to the application(s) from which priority is being claimed as recited by statute. Applicant understands that the statute is unambiguous in its specific reference language and does not require either a serial number or any characterization, such as “continuation” or “continuation-in-part,” for claiming priority to U.S. patent applications. Notwithstanding the foregoing, Applicant understands that the USPTO's computer programs have certain data entry requirements, and hence Applicant is designating the present application as a continuation-in-part of its parent applications as set forth above, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application(s).


All subject matter of the Related Applications and of any and all parent, grandparent, great-grandparent, etc. applications of the Related Applications is incorporated herein by reference to the extent such subject matter is not inconsistent herewith.


TECHNICAL FIELD

The present application relates, in general, to detection and/or treatment.


SUMMARY

In one aspect, a system includes, but is not limited to at least one arm; a control circuit coupled to said at least one arm; at least one receptacle coupled to said at least one arm; and at least one sensor coupled to said at least one arm, said system configured for implantation in an animal. In addition to the foregoing, other system aspects are described in the claims, drawings, and text forming a part of the present application.


In one aspect, a method includes but is not limited to: making a device, by providing a cavity for storing a receivable; and including at least one transmitting channel coupled to said cavity for delivering said receivable from said cavity to a predetermined location in an animal, cooperative with a monitoring system and a detecting system including logic or software operative for delivering said receivable. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.


In another aspect, a method includes but is not limited to: placing a device comprising a receiving unit for storing a deliverable and in communication with a pliable duct; directing said pliable duct to a location; and administering said deliverable from said receiving unit to said location cooperative with a guiding system and a detecting system. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.


In one or more various aspects, related systems include but are not limited to circuitry and/or programming for effecting the herein-referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to effect the herein-referenced method aspects depending upon the design choices of the system designer.


In addition to the foregoing, various other method and or system aspects are set forth and described in the text (e.g., claims and/or detailed description) and/or drawings of the present application.


The foregoing is a summary and thus contains, by necessity; simplifications, generalizations and omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is NOT intended to be in any way limiting. Other aspects, inventive features, and advantages of the devices and/or processes described herein, as defined solely by the claims, will become apparent in the non-limiting detailed description set forth herein.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a front-plan view of a device for perfusion management 100.



FIG. 2 is a front-plan view of another aspect of the device for perfusion management 100.



FIGS. 3A, 3B, and 3C show exploded views of various aspects of the device of FIG. 1, including an extensible finger 104.



FIG. 4 is a schematic view of the control circuit 110 and devices in communication with the control circuit 110.



FIG. 5 illustrates an example wherein the device for perfusion management 100 is placed in a selected location in a human body 501.





The use of the same symbols in different drawings typically indicates similar or identical items.


DETAILED DESCRIPTION

The present application uses formal outline headings for clarity of presentation. However, it is to be understood that the outline headings are for presentation purposes, and that different types of subject matter may be discussed throughout the application (e.g., device(s)/structure(s) may be described under the process(es)/operations heading(s) and/or process(es)/operations may be discussed under structure(s)/process(es) headings). Hence, the use of the formal outline headings is not intended to be in any way limiting.


1. Perfusion Management Device(s) and/or Process(es).


With reference now to FIG. 1, shown is a front plan view illustrative of various exemplary perfusion management device(s) and/or process(es). Accordingly, the present application first describes certain specific exemplary structures of FIG. 1; thereafter, the present application illustrates certain specific exemplary processes. Those having skill in the art will appreciate that the specific devices and processes described herein are intended as merely illustrative of their more general counterparts.


A. Structure(s) and or Device(s)


With reference to the figures, and with reference now to FIG. 1, shown is a front-plan view of a device for perfusion management 100. The device for perfusion management 100 includes a body portion 102 from which at least one arm 104 projects. A receptacle 106 within the body portion 102 contains a fluid, for example, a fluid for treatment. A controllable valve 108 provides a path through which the fluid may travel to the at least one arm 104.


A control circuit 110 provides a control signal that may open or close the control valve 108. The control circuit 110 may be connected to a sense line 112 that allows it to monitor the fluid levels within the receptacle 106. Additionally, a sense line 114 connects the control circuit 110 to a sensor 116 at the distal end of the at least one arm 104.


Referring now to FIG. 2, depicted is an aspect of the device for perfusion management 100 which includes the body portion 102 from which a set of at least one arm 104 projects. In one aspect, each of the at least one arm 104 is in fluid communication with a respective receptacle 106. Each receptacle 106 may be filled with a different fluid for delivery. In another approach, the one or more receptacles 106 may be coupled to a mixing chamber where the fluid contents of each receptacle 106 are present for mixing and the mixed contents enter the arm for delivery to a selected location. The choice of fluid in the receptacle 106 may depend, for example, on the purpose of the device, for example, treatment of colon cancer, treatment of breast cancer, or treatment of an arterial disease. The choice of fluid in the receptacle 106 includes, but is not limited to, for example, a chemical, a chemical compound, a protein, a lipoprotein, a glycoprotein, a sugar, a lipid, an antigen, an antibody, a cytokine, a peptide, a neurotransmitter, a hormone, an ion, a messenger a molecule, a nucleic acid, an engineered nucleic acid, a nucleic acid vector, a drug, a cell, a cell fragment, a cell organelle, a liposome, a pharmaceutical agent, a biological material, or a biological fraction. The receptacle 106 may also be utilized for storage and disposal of operational fluids. Also, although the exemplary embodiment described herein focuses primarily on fluid delivery, one skilled in the art will understand that fluid-like substances, such as gels, and fluidizable substances or non-fluid type substances, such as small solid particles, may be delivered in accordance with the invention. It will also be appreciated by those having skill in the art that the nature of the fluid in the receptacle 106 includes, for example, and is not limited to, a liquid, a solution, a mixture, a gel, a colloid, a colloid of a suitable viscosity, a suspension, an emulsion, or any material of low shear-strength for delivery to a site.


In one aspect one or more fluids are delivered to one or more of selected locations by the device for perfusion management 100. The selected location may be, for example, in proximity to or within a tumor, a circulatory system, an aorta, a vena cava, a site of therapy, or a site of investigation in an animal.


Continuing to refer to FIG. 2, a pump 218 provides fluid at a controlled flow rate for delivery to a site from the receptacle 106. It will be appreciated by those skilled in the art that the type of pump is not critical to the invention and may include, for example, a mechanical pump, a piezoelectric pump, an osmotic pump, a source of pressure, or a device for maintaining a positive flow of fluid through the device. Additionally, fluid flow may be further modulated with micro valves and self-pressurizing fluidic reservoirs. Moreover, in some applications, the fluid may be delivered without a pump. For example, fluid delivery may be controlled using a pressurized bladder, controlled dissolution or dilution of a material, a drip or gravity type of approach, or any other suitable approach to deliver an appropriate amount or an appropriate delivery-rate of the fluid.


With reference now to FIG. 3, depicted is an exploded view of the arm 104 showing a plurality of extended parts 304 with the sensor 116 at the distal end of each of the extended parts 304. In one aspect of the invention, the sensor 116 is an array of sensors, deployed from one or more portholes, at the distal end of each of the extended parts 304. In one approach, the portholes are sized and shaped to provide access through which the sensors 116 may be deployed. The portholes may include seals, stress relief or other features appropriate for proper mechanical deployment. In one approach, one or more of the portholes can be controllably opened or closed to provide communication exterior to the arm or main body. The sensor 116 may be retracted within the porthole and deployed through the porthole. Where the porthole can be opened and closed, the porthole can close to limit communication and can be opened for deployment. The array of sensors may include, but is not limited to, for example, sensors for detecting pressure, temperature, chemical, gas, electrolyte, flow, volume, composition, or concentration. In an alternate aspect of the invention, microelectrodes, such as, for example, solid-state microlectrodes, are sensitized with an agent for detecting a relevant interacter. Examples of the agent include, but are not limited to, for example, agonists of angiogenesis. The choice of sensor 116 depends on the physiological variable being monitored, treated, or controlled. The term “physiological variable” refers to any and all measurements relating to the functioning of a living organism in normal, sub-normal, or abnormal states.


Continuing to refer to FIG. 3 and referring now to FIG. 4, an operative tool 324 is coupled to the distal most extended part 304, or deployed from the porthole, or carried by the arm 104, further including a carrying line 334 in communication with the control circuit 110. The operative tool 324 includes, but is not limited to, for example, one or more of a combination of, a tool positioner, an ablation device, a laser, a vacuum, a siphon 326, an evacuation device, a fluid dispenser 328, a cauterizer 330, a stent 332, a tissue-liquefying device, or a source of an electric charge or electromagnetic radiation 422. The vacuum or the siphon 326 is employed for removing a cell, a mass of cells, a tissue, a fluid, a gel, a sample, a debris, a contaminant, or other material for which removal is desired or appropriate. The ablation device operates for perturbing or reducing the structural integrity or viability of a cell, a mass of cells, an assembly of biological materials exhibiting shear strength, or a tissue. The assembly of biological materials includes, for example, blood clots, cartilage, or bone. The source of an electric charge or electromagnetic radiation 422 includes, but is not limited to, for example, steady state electric currents, time-varying electric currents, alternating electric currents, radio waves, microwaves, ultraviolet rays, infra-red rays, optical rays, terahertz beams, and the like.


Continuing to refer to FIG. 3, it will be appreciated by those having skill in the art that the operative tool 324 may include a set of devices having general or “multi-purpose” utility. The operative tool 324 may include, but is not limited to, for example, a combination of the fluid dispenser 328, the siphon 326, and the ablation device. In this example the operative tool combination, for example, delivers the fluid or gel, ablates cells, and removes debris.


Continuing to refer to FIG. 3, the plurality of extended parts 304 may themselves be hollow forming a conduit for delivery of the fluid to a site, or for housing a circuitry coupling the control circuit 110 to the operative tool 324, or for housing a mechanism that guides the arm 104 or the plurality of extended parts 304.


With reference now to FIG. 4, illustrated is a schematic view of the control circuit 110 and devices in communication with the control circuit 110. The device for perfusion management 100 shows a data transmitter 410, and a data receiver 408 coupled to the control circuit 110. An antenna 412 may be used for transmitting data to the exterior wirelessly. The antenna 412 is shown diagrammatically, but may be a structure, such as a strip antenna, that may be integrated in a manner that does not impair or significantly perturb system performance. The control circuit 110 is depicted as having a processor 402 coupled to a memory 404 that provides data storage and retrieval capability, and a power source 406. Feedback circuitry or logic circuitry provides communication between the control circuit 110 and devices in communication with it. In some applications, a software program providing instructions may be stored in the memory 404 to control operation of the control circuitry or to store data gathered under control of the control circuitry. Additionally, the control circuit 110 may have components for system integrated digital data gathering, processing, storage, compression and transmission. These can provide data control capabilities and operation control capabilities. For example, the transmission components may communicate through the antenna 412 to a person, system, computer, or device exterior to the body. This communication can allow data gathered by the sensors to be displayed, stored or otherwise processed in the external environment. Additionally, this communication may allow for the processed data or a plurality of new data to be received from the exterior by the device for perfusion management 100. Data compression can allow the control circuitry to store data representing larger amounts of data to be stored in the memory 404 or to be transmitted to the exterior environment in a more efficient manner.


Continuing to refer to FIG. 4, one or more of the operative tools 324 are mounted on an actuator 414 which allows for the independent movement of each tool. Alternatively, one or more operative tools 324 may be mounted as a unit on one actuator 414 and moved as a group, for example, forming an aspirating-dispensing unit. For example, the fluid dispenser 328 and the siphon 326 may be mounted together as a group. The actuator 414 may be a motor, a piezo electrically driven actuator, a micromechanical or electrical effector, or the like.


Continuing to refer to FIG. 4, the arm 104 may include an imaging device deployed from the porthole or from the distal end of the arm 104 or carried by a carrying line 334. The term “imaging device” being used herein to designate in general those components, circuits, assemblies and sub-assemblies comprising electrical, optical, acoustic, or opto-electronic components. In one aspect, the control circuit 110 is coupled to the imaging device that includes a laser 418, or a source of light or scene-illuminating radiation, coupled to an optical feed line 420 to illuminate an area. A charge coupled device is positioned to capture data from the illuminated area and provides an electronic signal indicative of the area imaged. Conventional circuitry then produces a digital representation that may be displayed, stored in the memory 404, or otherwise processed. The displayed image may serve, for example, for guiding the arm 104 to the selected location or for determining the efficacy of a treatment or a procedure. One skilled in the art will recognize that the imaging device described herein is exemplary of imaging devices and that other imaging devices, including for example, raster and line-scanning imagers, nonvisible spectral imagers, and fluorescence imagers, may be included.


With reference now to FIG. 5, the device for perfusion management 100 is depicted implanted in an aorta 502 with the arm 104 traveling a blood vessel in a human body 501. Additionally, the device for perfusion management 100 is configured for full or partial placement in the human body 501. The configuration may incorporate a combination of the following criteria, including but not limited to, dimensions, composition, shape, power dissipation level, or texture. In one aspect, the body portion 102 is sized for implantation in proximity to the aorta 502 or the vena cava and the arm 104 is sized for traveling a blood vessel in an animal, for example, the human body 501. In this aspect, if the vasculature decreases two-fold, each of the extending parts 304 has about a two-fold decrease in diameter. The length of the arm 104, for example, depends upon the distance between the selected location and the location of the body portion 102, and the route traveled by the arm 104 to arrive at the selected location. It will be appreciated by those having skill in the art that the arm 104 including the one or more of the operative tools 324 is of a size, dimension or shape operable for traveling one or more blood vessel of decreasing or increasing luminal diameter. It will also be appreciated by those having skill in the art that the arm 104 and the one or more operative tool 324 may pass through the wall of a lumen, or trans-luminally, to the surrounding tissue for detecting, delivery of a treatment, or for sampling. It will also be appreciated by those having skill in the art that the trans-luminal mode described is not limited to blood vessels and includes the space or cavity of an organ or structure.


It will also be appreciated by those having skill in the art that the device for perfusion management 100 and its components, such as, for example, the arm 104, the plurality of extended parts 304, or one or more operative tools 324, has a size, dimension, shape, material, and properties of flexion, retraction, and extension to allow for the steering, guiding, or positioning of the components of the device for perfusion management 100. For example, the arm 104 may need to be steered around an occlusion or a fork in the vasculature. In this example, the arm 104 may need to retracted, repositioned and then extended in a new direction. Extending, retracting or repositioning of the arm 104 may be accomplished by techniques known in the art, for example, by using a guide wire or a by employing a shape polymer. In another aspect, the arm may be retracted and then “punched through” an occlusion to dislodge, penetrate, or grapple it. In this example, a laser beam, a shearing tool, a cutting tool, or a drug, for example, a lytic drug, may be employed to degrade or reduce the occlusion. In this example, subsequent to the dislodgement and degradation of the occlusion, the siphon 326 or an evacuation device is employed to evacuate any debris, before the arm 104 continues traveling the circulatory system. It will also be appreciated by those skilled in the art that the device for perfusion management 100 is not restricted to traveling the circulatory system but may be implanted in any tissue, such as, for example, nerve, epithelial, dermal, sub-dermal, connective, or muscle tissue. Additionally, the device for perfusion management 100 may be implanted in inter-tissue spaces, or inter-organ spaces, for example, those found within a body cavity.


In one aspect the device for perfusion management 100 includes an array of sensors 116 positioned across the plurality of extended parts 304 for monitoring, tracking, or mapping a gradient of temperature, pressure, flow, or material concentration in one or more locations. The one or more locations may be, for example, a tissue, an artery, or a vein. In another aspect the device for perfusion management 100 has an auto-correct feature for correcting a sub-normal or abnormal gradient of temperature, pressure, flow, or material concentration. In yet another aspect the device for perfusion management 100 has an auto-correct feature for detecting and correcting a sub-normal or abnormal gradient of temperature, pressure, flow, or material concentration.


The device for perfusion management 100 may be composed of materials known in the art, for example, a metal, a ceramic, a glass, a plastic, a polymer, a biologically compatible material, or a combination. For example, the device for perfusion management 100 may be made of helically-coiled stainless steel wire and coated with a polymer, such as, Teflon™. In another example, the device for perfusion management 100 may be made of helically-coiled stainless steel wire and coated with a polymer and impregnated with one or more of a biological material, for example, including but not limited to, anti coagulants, or inhibitors.


B. Operation(s) and/or Process(es)


Those having skill in the art will appreciate that some or all of the components of the device for perfusion management 100 may be present ex vivo. In one implementation, the device for perfusion management 100 is placed in proximity to the location on the animal, for example, the human body 501, and the at least one arm 104 directed to the selected location and an effective agent delivered in proximity to the selected location. The arm 104 may be retracted after such a delivery, leaving the device for perfusion management 100 in place at the location, until time for a future delivery of the effective agent or another procedure or operation. In this implementation, the majority of the device for perfusion management 100 is ex vivo while the arm 104 alternates between ex vivo and in vivo states.


In another aspect, some or all the components of the device for perfusion management 100 are present in vivo. In one implementation, the device for perfusion management 100 is placed in proximity to the location within the animal, for example, the human body 501, and the arm 104 directed to a selected location and an effective agent delivered in proximity to the selected location. The arm 104 may be retracted after such a delivery, leaving the device for perfusion management 100 in place at the location, until time for a future delivery or another operation. In this implementation, the majority of the device for perfusion management 100 is in vivo while the arm 104 alternates between retracted, partially retracted or unretracted states.


In one implementation, the device for perfusion management 100 is operable by a person. The person monitors, guides, positions, and performs other actions/operations or manages a response consistent with the device for perfusion management 100 being managed by the person. In such an implementation a separate display device can present imagery to aid the person. The imagery may be captured as described above with reference to FIG. 4, may be computer generated or may be captured by a separate imaging device internal to or external to the animal, for example, the human body 501. Actions may be performed under control of the person who may be on site or may be linked from a remote location, or the device for perfusion management 100 may be programmed to perform some or all functions automatically. For example, the device for perfusion management 100 may be programmed to perform functions, such as, lumen clearance, lumen maintenance, monitoring of concentrations, sending of alerts, delivery of one or more of the effective agent at timed intervals or locations, self-check, or self-diagnosis. It will be appreciated by those of skill in the art that the device for perfusion management 100 may be programmed for complete automatic operation of one or more functions.


C. Variation(s), and/or Implementation(s)


Those having skill in the art will recognize that the present application teaches modifications of the devices, structures, and/or processes within the spirit of the teaching herein. For example, the device for perfusion management 100 need not be limited to managing perfusion. The device provides a mechanism for exploring one or more regions and/or reaching a location within an animal, obtaining information, communicating this information, performing operations, performing procedures, or providing treatment. The treatment includes but is not limited to, for example, treatment of a subnormal, abnormal or pathological condition. In another example, the device for perfusion management 100 may find utility in the management of physiological functions, the detection or elimination of pathological functions or conditions, and/or treatment of a disease or a pathological state of non-human animals. Other modifications of the subject matter herein will be appreciated by one of skill in the art in light of the teachings herein.


The foregoing described aspects depict different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality.


While particular aspects of the present subject matter described herein have been shown and described, it will be obvious to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from this subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this subject matter described herein. Furthermore, it is to be understood that the invention is defined solely by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to inventions containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations), etc.

Claims
  • 1. A device for perfusion management comprising: at least one extensible conduit operable to deliver one or more receivables to at least one bodily location; andan array of sensors that are distributed along a length of the at least one extensible conduit and that are operable to obtain information associated with two or more positions.
  • 2. The device for perfusion management of claim 1, wherein the at least one extensible conduit is articulatable.
  • 3. The device for perfusion management of claim 1, wherein the at least one extensible conduit is flexible.
  • 4. The device for perfusion management of claim 1, wherein the at least one extensible conduit is retractable.
  • 5. The device for perfusion management of claim 1, further comprising: at least one other conduit.
  • 6. The device for perfusion management of claim 1, wherein the at least one extensible conduit is guidable.
  • 7. The device for perfusion management of claim 1, wherein the at least one extensible conduit includes one or more stent portions.
  • 8. The device for perfusion management of claim 1, wherein at least some of the array of sensors are operable to obtain composition information.
  • 9. The device for perfusion management of claim 1, wherein at least some of the array of sensors are operable to obtain image information.
  • 10. The device for perfusion management of claim 1, wherein at least some of the array of sensors are distributed along a length of one or more sidewalls of the at least one extensible conduit.
  • 11. The device for perfusion management of claim 1, wherein at least some of the array of sensors are distributed among two or more segments of the at least one extensible conduit.
  • 12. The device for perfusion management of claim 1, wherein the array of sensors includes three or more sensors.
  • 13. The device for perfusion management of claim 1, further comprising: one or more reservoirs operable to contain one or more receivables.
  • 14. The device for perfusion management of claim 1, further comprising: one or more mixing units operable to mix one or more receivables.
  • 15. The device for perfusion management of claim 1, further comprising: one or more polymers operable to perform one or more actions.
  • 16. The device for perfusion management of claim 1, further comprising: one or more tools.
  • 17. The device for perfusion management of claim 16, wherein at least some of the one or more tools are operable to obtain at least some material.
  • 18. The device for perfusion management of claim 16, wherein at least some of the one or more tools are associated with one or more portholes of the at least one extensible conduit.
  • 19. The device for perfusion management of claim 1, further comprising: at least one communication unit.
  • 20. The device for perfusion management of claim 1, further comprising: at least one source of radiation.
  • 21. The device for perfusion management of claim 1, further comprising: at least one source of current.
  • 22. The device for perfusion management of claim 1, further comprising: control circuitry configured to signal for delivery of one or more receivables in response to information obtained from at least some of the array of sensors.
  • 23. The device for perfusion management of claim 1, wherein the device is fully implantable.
  • 24. The device for perfusion management of claim 1, wherein the device is at least partially programmably controllable.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is related to, claims the earliest available effective filing date(s) from the following listed application(s) (the “Related Applications”) (e.g., claims earliest available priority dates for other than provisional patent applications or claims benefits under 35 USC § 119(e) for provisional patent applications), and incorporates by reference in its entirety all subject matter of the following listed applications(s) to the extent such subject matter is not inconsistent herewith; the present application also claims the earliest available effective filing date(s) from, and also incorporates by reference in its entirety all subject matter of any and all parent, grandparent, great-grandparent, etc. applications of the “Related Application(s).”

US Referenced Citations (426)
Number Name Date Kind
3391697 Greatbatch Jul 1968 A
3821469 Whetstone et al. Jun 1974 A
3837339 Aisenberg et al. Sep 1974 A
3941127 Froning Mar 1976 A
3983474 Kuipers Sep 1976 A
4054881 Raab Oct 1977 A
4119900 Kremnitz Oct 1978 A
4202349 Jones May 1980 A
4262306 Renner Apr 1981 A
4267831 Aguilar May 1981 A
4314251 Raab Feb 1982 A
4317078 Weed et al. Feb 1982 A
4339953 Iwasaki Jul 1982 A
4367741 Michaels Jan 1983 A
4396885 Constant Aug 1983 A
4403321 Krüger Sep 1983 A
4418422 Richter et al. Nov 1983 A
4431005 McCormick Feb 1984 A
4583190 Salb Apr 1986 A
4585652 Miller et al. Apr 1986 A
4628928 Lowell Dec 1986 A
4638798 Shelden et al. Jan 1987 A
4642786 Hansen Feb 1987 A
4651732 Frederick Mar 1987 A
4658214 Petersen Apr 1987 A
4714460 Calderon Dec 1987 A
4717381 Papantonakos Jan 1988 A
4733661 Palestrant Mar 1988 A
4750488 Wuchinich et al. Jun 1988 A
4763667 Manzo Aug 1988 A
4769006 Papantonakos Sep 1988 A
4771772 DeWitt Sep 1988 A
4795434 Kujawski Jan 1989 A
4800898 Hess et al. Jan 1989 A
4805615 Carol Feb 1989 A
4817601 Roth et al. Apr 1989 A
4871351 Feingold Oct 1989 A
4889526 Rauscher et al. Dec 1989 A
4905689 Stack et al. Mar 1990 A
4943296 Funakubo et al. Jul 1990 A
4944659 Labbe et al. Jul 1990 A
4962453 Pong et al. Oct 1990 A
4994071 MacGregor Feb 1991 A
5019372 Folkman et al. May 1991 A
5031109 Gloton Jul 1991 A
5051906 Evans, Jr. et al. Sep 1991 A
5078140 Kwoh Jan 1992 A
5086401 Glassman et al. Feb 1992 A
5153827 Coutre et al. Oct 1992 A
5165064 Mattaboni Nov 1992 A
5176638 Don Michael Jan 1993 A
5188111 Yates et al. Feb 1993 A
5204814 Noonan et al. Apr 1993 A
5234457 Andersen Aug 1993 A
5269303 Wernicke et al. Dec 1993 A
5279607 Schentag et al. Jan 1994 A
5310404 Gyory et al. May 1994 A
5313835 Dunn May 1994 A
5314451 Mulier May 1994 A
5321614 Ashworth Jun 1994 A
5335657 Terry, Jr. et al. Aug 1994 A
5337732 Grundfest et al. Aug 1994 A
5338625 Bates et al. Aug 1994 A
5339051 Koehler et al. Aug 1994 A
5353807 DeMarco Oct 1994 A
5374285 Vaiani et al. Dec 1994 A
5381786 Spears Jan 1995 A
5386741 Rennex Feb 1995 A
5395390 Simon et al. Mar 1995 A
5398670 Ortiz et al. Mar 1995 A
5403311 Abele et al. Apr 1995 A
5411551 Winston et al. May 1995 A
5437660 Johnson et al. Aug 1995 A
5476450 Ruggio Dec 1995 A
5497147 Arms et al. Mar 1996 A
5502638 Takenaka Mar 1996 A
5507287 Palcic et al. Apr 1996 A
5522394 Zurbrugg Jun 1996 A
5551953 Lattin et al. Sep 1996 A
5554914 Miyazawa Sep 1996 A
5569968 Lal et al. Oct 1996 A
5574347 Neubauer Nov 1996 A
5589932 Garcia-Rubio et al. Dec 1996 A
5593434 Williams Jan 1997 A
5599324 McAlister et al. Feb 1997 A
5610488 Miyazawa Mar 1997 A
5624398 Smith et al. Apr 1997 A
5632754 Farley et al. May 1997 A
5643296 Hundertmark et al. Jul 1997 A
5662587 Grundfest et al. Sep 1997 A
5669874 Feiring Sep 1997 A
5670329 Oberhardt Sep 1997 A
5674276 Andersen et al. Oct 1997 A
5688269 Newton et al. Nov 1997 A
5695457 St. Goar et al. Dec 1997 A
5697967 Dinh et al. Dec 1997 A
5702432 Chen et al. Dec 1997 A
5705293 Hobson Jan 1998 A
5728089 Lal et al. Mar 1998 A
5735276 Lemelson Apr 1998 A
5737279 Carter Apr 1998 A
5758298 Guldner May 1998 A
5782798 Rise Jul 1998 A
5804563 Still et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5819736 Avny et al. Oct 1998 A
5827190 Palcic et al. Oct 1998 A
5830179 Mikus et al. Nov 1998 A
5830207 Leeb et al. Nov 1998 A
5831012 Nilsson et al. Nov 1998 A
5833603 Kovacs et al. Nov 1998 A
5843139 Goedeke et al. Dec 1998 A
5855801 Lin et al. Jan 1999 A
5865754 Sevick-Muraca et al. Feb 1999 A
5873835 Hastings et al. Feb 1999 A
5908027 Butterfield et al. Jun 1999 A
5921982 Lesh et al. Jul 1999 A
5947119 Reznick Sep 1999 A
5951600 Lemelson Sep 1999 A
5954675 Dellagatta Sep 1999 A
5964773 Greenstein Oct 1999 A
6004269 Crowley et al. Dec 1999 A
6016449 Fischell et al. Jan 2000 A
6019729 Itoigawa et al. Feb 2000 A
6022316 Eppstein et al. Feb 2000 A
6053873 Govari et al. Apr 2000 A
6086528 Adair Jul 2000 A
6102845 Woodard et al. Aug 2000 A
6108597 Kirchner et al. Aug 2000 A
6111520 Allen et al. Aug 2000 A
6128538 Fischell et al. Oct 2000 A
6134474 Fischell et al. Oct 2000 A
6149603 Parker Nov 2000 A
6159230 Samuels Dec 2000 A
6164284 Schulman et al. Dec 2000 A
6170488 Spillman, Jr. et al. Jan 2001 B1
6175757 Watkins et al. Jan 2001 B1
6179789 Tu et al. Jan 2001 B1
6185452 Schulman et al. Feb 2001 B1
6186986 Berg et al. Feb 2001 B1
6187599 Asher et al. Feb 2001 B1
6197013 Reed et al. Mar 2001 B1
6219577 Brown, III et al. Apr 2001 B1
6221099 Andersen et al. Apr 2001 B1
6240312 Alfano et al. May 2001 B1
6240316 Richmond et al. May 2001 B1
6248345 Goldenheim et al. Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6255361 Rajagopalan et al. Jul 2001 B1
6255793 Peless et al. Jul 2001 B1
6263245 Snell Jul 2001 B1
6278379 Allen et al. Aug 2001 B1
6280386 Alfano et al. Aug 2001 B1
6289270 Baumgarten Sep 2001 B1
6295990 Lewis et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6322532 D'Sa et al. Nov 2001 B1
6337997 Rise Jan 2002 B1
6372248 Qin et al. Apr 2002 B1
6383162 Sugarbaker May 2002 B1
6384741 O'Leary, Sr. May 2002 B1
6385472 Hall et al. May 2002 B1
6398280 Parker et al. Jun 2002 B1
6400980 Lemelson Jun 2002 B1
6402678 Fischell et al. Jun 2002 B1
6409674 Brockway et al. Jun 2002 B1
6417641 Peless et al. Jul 2002 B2
6431171 Burton Aug 2002 B1
6436120 Meglin Aug 2002 B1
6442413 Silver Aug 2002 B1
6450937 Mercereau et al. Sep 2002 B1
6453199 Kobozev Sep 2002 B1
6464687 Ishikawa et al. Oct 2002 B1
6475639 Shahinpoor et al. Nov 2002 B2
6490483 Willis Dec 2002 B2
6491618 Ganz Dec 2002 B1
6493607 Bourne et al. Dec 2002 B1
6497714 Ishikawa et al. Dec 2002 B1
6500174 Maguire et al. Dec 2002 B1
6512949 Combs et al. Jan 2003 B1
6512950 Li et al. Jan 2003 B2
6514237 Maseda Feb 2003 B1
6530950 Alvarado et al. Mar 2003 B1
6547723 Ouchi Apr 2003 B1
6547825 Shimizu et al. Apr 2003 B1
6548982 Papanikolopoulos et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6585763 Keilman et al. Jul 2003 B1
6591137 Fischell et al. Jul 2003 B1
6592567 Levin et al. Jul 2003 B1
6597954 Pless et al. Jul 2003 B1
6607553 Healy et al. Aug 2003 B1
6612982 Ouchi Sep 2003 B1
6616676 Bashiri et al. Sep 2003 B2
6623519 Edwin et al. Sep 2003 B2
6632216 Houzego et al. Oct 2003 B2
6638273 Farley et al. Oct 2003 B1
6648908 Dobak, III et al. Nov 2003 B2
6666860 Takahashi Dec 2003 B1
6669683 Santini, Jr. et al. Dec 2003 B2
6673042 Samson et al. Jan 2004 B1
6673363 Luo et al. Jan 2004 B2
6679893 Tran Jan 2004 B1
6709388 Mosse et al. Mar 2004 B1
6711423 Colvin, Jr. Mar 2004 B2
6712835 Mazzocchi et al. Mar 2004 B2
6719684 Kim et al. Apr 2004 B2
6723092 Brown et al. Apr 2004 B2
6733485 Whitehurst et al. May 2004 B1
6735474 Loeb et al. May 2004 B1
6735475 Whitehurst et al. May 2004 B1
6743211 Prausnitz et al. Jun 2004 B1
6754536 Swoyer et al. Jun 2004 B2
6755802 Bell Jun 2004 B2
6755803 Le et al. Jun 2004 B1
6764441 Chiel et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6773429 Sheppard, Jr. et al. Aug 2004 B2
6776165 Jin Aug 2004 B2
6797522 Still et al. Sep 2004 B1
6802811 Slepian Oct 2004 B1
6816632 Slice Nov 2004 B1
6824508 Kim et al. Nov 2004 B2
6824510 Kim et al. Nov 2004 B2
6824561 Soykan et al. Nov 2004 B2
6834118 Kim Dec 2004 B2
6849183 Gorsuch et al. Feb 2005 B2
6855115 Fonseca et al. Feb 2005 B2
6860867 Seward et al. Mar 2005 B2
6861001 Lee et al. Mar 2005 B2
6866626 Long et al. Mar 2005 B2
6869430 Balbierz et al. Mar 2005 B2
6875209 Zvuloni et al. Apr 2005 B2
6882881 Lesser et al. Apr 2005 B1
6889091 Hine et al. May 2005 B2
6890303 Fitz May 2005 B2
6898464 Edell et al. May 2005 B2
6911004 Kim et al. Jun 2005 B2
6911496 Rhee et al. Jun 2005 B2
6920359 Meadows et al. Jul 2005 B2
6921413 Mahadevan-Jansen et al. Jul 2005 B2
6925357 Wang et al. Aug 2005 B2
6929636 Von Alten Aug 2005 B1
6936003 Iddan Aug 2005 B2
6939290 Iddan Sep 2005 B2
6939376 Shulze et al. Sep 2005 B2
6950707 Whitehurst Sep 2005 B2
6953589 Trautman et al. Oct 2005 B1
6958034 Iddan Oct 2005 B2
6959215 Gliner et al. Oct 2005 B2
6960227 Jones et al. Nov 2005 B2
6963792 Green Nov 2005 B1
6984205 Gazdzinski Jan 2006 B2
6984952 Peless et al. Jan 2006 B2
6991617 Hektner et al. Jan 2006 B2
7003352 Whitehurst Feb 2006 B1
7013177 Whitehurst et al. Mar 2006 B1
7020231 Frey et al. Mar 2006 B1
7027134 Garcia-Rubio et al. Apr 2006 B1
7037343 Imran May 2006 B2
7039453 Mullick et al. May 2006 B2
7042184 Oleynikov et al. May 2006 B2
7044911 Drinan et al. May 2006 B2
RE39133 Clayton et al. Jun 2006 E
7066180 Aylsworth et al. Jun 2006 B2
7083578 Lewkowicz et al. Aug 2006 B2
7101386 Dobak, III Sep 2006 B2
7115109 Gerdts et al. Oct 2006 B2
7118531 Krill Oct 2006 B2
7125382 Zhou et al. Oct 2006 B2
7131979 DiCarlo et al. Nov 2006 B2
7160258 Imran et al. Jan 2007 B2
7171285 Kim et al. Jan 2007 B2
7181261 Silver et al. Feb 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7212110 Martin et May 2007 B1
7214182 Shimizu et al. May 2007 B2
7228162 Ward et al. Jun 2007 B2
7236821 Cates et al. Jun 2007 B2
7245954 Glukhovsky Jul 2007 B2
7297113 Russell et al. Nov 2007 B1
7341577 Gill Mar 2008 B2
7365509 Park et al. Apr 2008 B2
7365614 McCorquodale et al. Apr 2008 B2
7383071 Russell et al. Jun 2008 B1
7398734 Jean Jul 2008 B1
7451537 Liu et al. Nov 2008 B2
7486967 Pan et al. Feb 2009 B2
7572228 Wolinsky et al. Aug 2009 B2
7596403 Horn Sep 2009 B2
7625338 Gilad et al. Dec 2009 B2
7684840 Palti Mar 2010 B2
7713196 Baker, Jr. May 2010 B2
7736300 Ziegler et al. Jun 2010 B2
7744542 Piaget et al. Jun 2010 B2
7801626 Moser Sep 2010 B2
7840271 Kieval et al. Nov 2010 B2
7857767 Ferren et al. Dec 2010 B2
20010029348 Willis Oct 2001 A1
20010051766 Gazdzinski Dec 2001 A1
20020026188 Balbierz et al. Feb 2002 A1
20020065509 Lebel et al. May 2002 A1
20020068080 Lerner Jun 2002 A1
20020090388 Humes et al. Jul 2002 A1
20020103417 Gazdzinski Aug 2002 A1
20020116029 Miller et al. Aug 2002 A1
20020116034 Miller et al. Aug 2002 A1
20020120263 Brown et al. Aug 2002 A1
20020147480 Mamayek Oct 2002 A1
20020156462 Stultz Oct 2002 A1
20020165592 Glukhovsky et al. Nov 2002 A1
20020169436 Gurm et al. Nov 2002 A1
20020171385 Kim et al. Nov 2002 A1
20020183721 Santini, Jr. et al. Dec 2002 A1
20020188323 Penner et al. Dec 2002 A1
20020193679 Malave et al. Dec 2002 A1
20020193874 Crowley Dec 2002 A1
20020198470 Imran et al. Dec 2002 A1
20020198521 Maguire Dec 2002 A1
20020198604 Schulman et al. Dec 2002 A1
20030004403 Drinan et al. Jan 2003 A1
20030023150 Yokoi et al. Jan 2003 A1
20030024534 Silvestri et al. Feb 2003 A1
20030040704 Dorros et al. Feb 2003 A1
20030060723 Joo et al. Mar 2003 A1
20030065250 Chiel et al. Apr 2003 A1
20030065358 Frecker et al. Apr 2003 A1
20030069475 Banik et al. Apr 2003 A1
20030069523 Williams et al. Apr 2003 A1
20030093031 Long et al. May 2003 A1
20030151524 Clark Aug 2003 A1
20030152823 Heller Aug 2003 A1
20030153866 Long et al. Aug 2003 A1
20030158584 Cates et al. Aug 2003 A1
20030163177 Eggers et al. Aug 2003 A1
20030167000 Mullick et al. Sep 2003 A1
20030191430 D'Andrea et al. Oct 2003 A1
20030214579 Iddan Nov 2003 A1
20030214580 Iddan Nov 2003 A1
20030220556 Porat et al. Nov 2003 A1
20040008853 Pelrine et al. Jan 2004 A1
20040018508 Friedman Jan 2004 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040034332 Uhland Feb 2004 A1
20040064093 Hektner et al. Apr 2004 A1
20040073177 Hickle Apr 2004 A1
20040073190 Deem et al. Apr 2004 A1
20040092825 Madar et al. May 2004 A1
20040097805 Verard et al. May 2004 A1
20040097819 Duarte May 2004 A1
20040098030 Makower et al. May 2004 A1
20040111019 Long Jun 2004 A1
20040133147 Woo Jul 2004 A1
20040138517 Osorio et al. Jul 2004 A1
20040147939 Rabkin et al. Jul 2004 A1
20040148034 Kagan et al. Jul 2004 A1
20040152988 Weirich Aug 2004 A1
20040162469 Imran Aug 2004 A1
20040162501 Imran Aug 2004 A1
20040176664 Iddan Sep 2004 A1
20040193010 Fujimori et al. Sep 2004 A1
20040199246 Chu et al. Oct 2004 A1
20040225325 Bonutti Nov 2004 A1
20040225326 Weiner et al. Nov 2004 A1
20040260391 Santini, Jr. et al. Dec 2004 A1
20040267240 Gross et al. Dec 2004 A1
20050004474 Iddan Jan 2005 A1
20050004553 Douk Jan 2005 A1
20050021023 Guglielmi et al. Jan 2005 A1
20050027236 Douk Feb 2005 A1
20050043583 Killmann et al. Feb 2005 A1
20050058701 Gross et al. Mar 2005 A1
20050062562 Ries Mar 2005 A1
20050065592 Holzer Mar 2005 A1
20050069925 Ford et al. Mar 2005 A1
20050079132 Wang et al. Apr 2005 A1
20050107870 Wang et al. May 2005 A1
20050113460 Glick May 2005 A1
20050121411 Cohen Jun 2005 A1
20050126916 Lockard et al. Jun 2005 A1
20050149170 Van Tassel et al. Jul 2005 A1
20050151524 Sae-Ueng et al. Jul 2005 A1
20050171418 Lin Aug 2005 A1
20050171434 Madden et al. Aug 2005 A1
20050177223 Palmaz Aug 2005 A1
20050182482 Wang et al. Aug 2005 A1
20050203613 Arney et al. Sep 2005 A1
20050215911 Alfano et al. Sep 2005 A1
20050216074 Sahatjian et al. Sep 2005 A1
20050221529 Bang et al. Oct 2005 A1
20050228259 Glukhovsky et al. Oct 2005 A1
20050234393 Wood, Jr. Oct 2005 A1
20050234440 Wood, Jr. Oct 2005 A1
20050238689 Carpenter et al. Oct 2005 A1
20050272806 Falotico et al. Dec 2005 A1
20050272974 Iddan Dec 2005 A1
20050277839 Alderman et al. Dec 2005 A1
20050278020 Wang et al. Dec 2005 A1
20060004395 Chiel et al. Jan 2006 A1
20060009810 Mann et al. Jan 2006 A1
20060015146 Girouard et al. Jan 2006 A1
20060037617 Walke et al. Feb 2006 A1
20060042631 Martin et al. Mar 2006 A1
20060074479 Bailey et al. Apr 2006 A1
20060119304 Farritor et al. Jun 2006 A1
20060152309 Mintchev et al. Jul 2006 A1
20060167339 Gilad et al. Jul 2006 A1
20060169294 Kaler et al. Aug 2006 A1
20060235275 Rabinovitz et al. Oct 2006 A1
20060252987 Hasegawa et al. Nov 2006 A1
20070010868 Ferren et al. Jan 2007 A1
20070066929 Ferren et al. Mar 2007 A1
20070088334 Hillis et al. Apr 2007 A1
20070156211 Ferren et al. Jul 2007 A1
20070225634 Ferren et al. Sep 2007 A1
20080063703 Gross et al. Mar 2008 A1
20080066929 Costa et al. Mar 2008 A1
20080121054 Goldenberg et al. May 2008 A1
20080241847 Hoon et al. Oct 2008 A1
20080243056 Hillis et al. Oct 2008 A1
20080266106 Lim et al. Oct 2008 A1
20090062646 Creighton, IV et al. Mar 2009 A1
20090069821 Farritor et al. Mar 2009 A1
20090082652 Koh et al. Mar 2009 A1
20090182388 Von Arx et al. Jul 2009 A1
Foreign Referenced Citations (22)
Number Date Country
9981027.1 Oct 2001 CN
1 245 201 Oct 2002 EP
1 618 831 Jan 2006 EP
2 163 206 Mar 2010 EP
2001-506871 Mar 1998 JP
2002-153569 May 2002 JP
2005-74229 Mar 2005 JP
WO 9639999 Dec 1996 WO
WO 9809582 Mar 1998 WO
WO 9814243 Apr 1998 WO
WO 9920335 Apr 1999 WO
WO 9944665 Sep 1999 WO
WO 0069515 Nov 2000 WO
WO 0108548 Feb 2001 WO
WO 0124731 Apr 2001 WO
WO 03072157 Sep 2003 WO
WO 03090618 Nov 2003 WO
WO 03106966 Dec 2003 WO
WO 2004028335 Apr 2004 WO
WO 2004058041 Jul 2004 WO
WO 2004086958 Oct 2004 WO
WO 2005082248 Sep 2005 WO
Related Publications (1)
Number Date Country
20050234399 A1 Oct 2005 US
Continuation in Parts (3)
Number Date Country
Parent 10827572 Apr 2004 US
Child 10827576 US
Parent 10827578 Apr 2004 US
Child 10827572 US
Parent 10827390 Apr 2004 US
Child 10827578 US